Therapeutic effects of D-cycloserine in mouse models of IBD and CAC: Targeting NLRP3 inflammasome and intestinal barrier integrity
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.115209 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Shengwei Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China; Shenzhen Institute of Guangdong Ocean University, Organ…. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes, Inflammatory Bowel Diseases, Cycloserine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
D-Cycloserine (DCS), a broad-spectrum antibiotic and NMDA receptor modulator, exhibits immunomodulatory effects beyond its known neurological and antimicrobial functions. This study investigated DCS's therapeutic potential in inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CAC) using in vitro and in vivo models. In lipopolysaccharide (LPS)-stimulated NCM460 cells, DCS inhibited NLRP3 inflammasome activation and restored tight junction protein expression. In dextran sulfate sodium (DSS)-induced murine colitis, both preventive and therapeutic DCS regimens attenuated inflammation, reduced histopathological damage, and preserved intestinal barrier integrity. In azoxymethane (AOM)/DSS-induced CAC, DCS decreased tumor burden and reduced Ki-67+ cell proliferation without systemic toxicity. These findings position DCS as a promising dual-target candidate for IBD and CAC management through NLRP3-caspase-1-GSDMD pathway inhibition and epithelial barrier maintenance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China; Shenzhen Institute of Guangdong Ocean University, Organization X, Shenzheng 518000, China; College of Coastal Agricultural Sc…
- College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
- Shenzhen Institute of Guangdong Ocean University, Organization X, Shenzheng 518000, China; College of Coastal Agricultural Sciences, Guangdong Ocean University, Zhanjiang 524088, China.
- Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt; Department of Medical Pharmacology, Faculty of Medicine, Atatürk University, Erzurum 25240, Turkey.
- College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China. Electronic address: yangsh@scau.edu.cn.
Zitieren
APA
Chen, S., Yan, L., Zeng, J., Meng, W., Zhuang, J., Chen, F., Guo, Y., Abd El-Aty, A. M., Ju, X., & Yang, S. (2025). Therapeutic effects of D-cycloserine in mouse models of IBD and CAC: Targeting NLRP3 inflammasome and intestinal barrier integrity. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115209
Vancouver
Chen S, Yan L, Zeng J, Meng W, Zhuang J, Chen F, et al. Therapeutic effects of D-cycloserine in mouse models of IBD and CAC: Targeting NLRP3 inflammasome and intestinal barrier integrity. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115209
BibTeX
@article{Chen2025,
author = {Chen, Shengwei and Yan, Lizhuowen and Zeng, Jingtao and Meng, Wei and Zhuang, Jionghan and Chen, Fengying and Guo, Yonglong and Abd El-Aty, A M and Ju, Xianghong and Yang, Shihua},
title = {Therapeutic effects of D-cycloserine in mouse models of IBD and CAC: Targeting NLRP3 inflammasome and intestinal barrier integrity},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.115209}
}
EUVIMED